Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 39 of 1714:
29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49
Gene Compound Assay Inh Ic50 Ki View
5-hydroxytryptamine (serotonin) receptor 2B PYRILAMINE Serotonin 5-HT2B 70% 2.788uM 1.774uM View
adrenergic receptor, alpha 2a PYRILAMINE Imidazoline I2, Central 70% 3.339uM 2.226uM View
adrenergic receptor, alpha 2c (Non-specific probe) PYRILAMINE Imidazoline I2, Central 70% 3.339uM 2.226uM View
Sigma-2 Receptor PROMAZINE Sigma2 70% 2.538uM 1.562uM View
adrenergic receptor, alpha 2a TERBINAFINE Adrenergic alpha2A 70% 5.7029uM 2.1386uM View
adrenergic receptor, alpha 1b CYCLIZINE Adrenergic alpha1B 70% 2.492uM 1.379uM View
acetylcholinesterase (YT blood group) NIZATIDINE Acetylcholinesterase 70% 5.6146uM NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase NIZATIDINE Acetylcholinesterase 70% 5.6146uM NoneNone View
acetylcholinesterase NIZATIDINE Acetylcholinesterase 70% 5.6146uM NoneNone View
dopamine receptor D3 PENTAMIDINE Dopamine D3 70% 3.998uM 1.358uM View
sodium channel associated protein 1 LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel associated protein 2 LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
acetylcholinesterase 4-OCTYLPHENOL Acetylcholinesterase 67% 11.471uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B TIRILAZAD Serotonin 5-HT2B 67% 18.507uM 11.777uM View
adenosine A2a receptor 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Adenosine A2A 67% NoneNone NoneNone View
AT hook, DNA binding motif, containing 1 (DBSS) CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid A receptor, theta CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid A receptor, gamma 2 CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid A receptor, alpha 2 CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid A receptor, alpha 1 CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid A receptor, delta CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid A receptor, gamma 1 CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
gamma-aminobutyric acid A receptor, pi CLOTRIMAZOLE GABAA, Chloride Channel, TBOB 67% 18.751uM 16.811uM View
tachykinin receptor 2 LOVASTATIN Tachykinin NK2 67% 28.224uM 9.408uM View
adrenergic receptor, alpha 2a TERAZOSIN Adrenergic alpha2A 67% 13.832uM 5.187uM View
androgen receptor TAMOXIFEN Testosterone 67% 22.662uM 15.108uM View
dopamine receptor D4 CLEMASTINE Dopamine D4.2 67% NoneNone NoneNone View
Sigma-2 Receptor DEXFENFLURAMINE Sigma2 67% NoneNone NoneNone View
opioid receptor, kappa 1 FLUPHENAZINE Opiate kappa 67% 24.727uM 9.891uM View
mu-opioid receptor MOR FLUPHENAZINE Opiate mu 67% 20.745uM 8.421uM View
phosphodiesterase 3B MC 288769 Phosphodiesterase PDE3 67% 23.569uM NoneNone View
phosphodiesterase 3A MC 288769 Phosphodiesterase PDE3 67% 23.569uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A R-(+)-PROPRANOLOL Serotonin 5-HT2A 67% NoneNone NoneNone View
adrenergic receptor, alpha 1a GENTIAN VIOLET Adrenergic alpha1A 67% NoneNone NoneNone View
epidermal growth factor receptor ISOTRETINOIN Protein Tyrosine Kinase, EGF Receptor 67% NoneNone NoneNone View
adrenergic receptor, beta 2 LYSERGOL Adrenergic beta2 67% NoneNone NoneNone View
dopamine receptor 2 MEPAZINE Dopamine D2L 67% NoneNone NoneNone View
thromboxane A synthase 1 VINCRISTINE Thromboxane Synthetase 67% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) VINCRISTINE Thromboxane Synthetase 67% NoneNone NoneNone View
opioid receptor, kappa 1 QUINACRINE Opiate kappa 67% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 SERTRALINE Serotonin 5-HT6 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase TRANS-PLATINUM(II)DIAMMINE DICHLORIDE HMG-CoA Reductase 67% NoneNone NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase TRANS-PLATINUM(II)DIAMMINE DICHLORIDE HMG-CoA Reductase 67% NoneNone NoneNone View
5-hydroxytryptamine receptor 6 HEXACHLOROPHENE Serotonin 5-HT6 67% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific ZINC CHLORIDE Phosphodiesterase PDE5 67% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific ZINC CHLORIDE Phosphodiesterase PDE5 67% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 DESLORATADINE CYP450-3A4 Inhibition 67% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase HYDROXYCHLOROQUINE CYP450-2D6 Inhibition 67% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel associated protein 1 DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel associated protein 2 DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, gamma subunit 5 HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, gamma subunit 4 HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, gamma subunit 3 HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, gamma subunit 2 HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, gamma subunit 1 HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, beta 4 subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, beta 3 subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, beta 2 subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, alpha 1F subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, beta 1 subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
adrenergic receptor, alpha 2b DESLORATADINE Adrenergic alpha2B 71% 2.146uM .98uM View
calcium channel, voltage-dependent, gamma subunit 8 HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
calcium channel, voltage-dependent, gamma subunit 7 HALOPERIDOL Calcium Channel Type L, Benzothiazepine 71% 1.717uM 1.527uM View
arachidonate 15-lipoxygenase, second type MONOBENZONE Lipoxygenase 15-LO 71% 4.892uM NoneNone View
arachidonate 15-lipoxygenase MONOBENZONE Lipoxygenase 15-LO 71% 4.892uM NoneNone View
arachidonate 15-lipoxygenase MONOBENZONE Lipoxygenase 15-LO 71% 4.892uM NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, beta 1 subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, gamma subunit 8 GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, gamma subunit 7 GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, gamma subunit 6 GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, gamma subunit 5 GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, gamma subunit 4 GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, gamma subunit 3 GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, gamma subunit 2 GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, gamma subunit 1 GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, beta 4 subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, beta 3 subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, beta 2 subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit GENTIAN VIOLET Calcium Channel Type L, Phenylalkylamine 71% 3.441uM 3.346uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 MOSAPRIDE Serotonin Transporter 71% 3.8117uM 2.0249uM View
amiloride-sensitive cation channel 5, intestinal LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha LABETALOL Sodium Channel, Site 2 69% NoneNone NoneNone View
adenosine A2a receptor GENISTEIN Adenosine A2A 69% 17.442uM 9.792uM View
5-hydroxytryptamine (serotonin) receptor 2B EPERISONE Serotonin 5-HT2B 69% NoneNone NoneNone View
dopamine receptor 2 VERAPAMIL Dopamine D2L 69% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Serotonin 5-HT2B 69% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A RWJ-68354 Serotonin 5-HT2A 69% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B RWJ-68354 Serotonin 5-HT2B 69% NoneNone NoneNone View
monoamine oxidase A LEFLUNOMIDE Monoamine Oxidase MAOA 69% 20.696uM NoneNone View
monoamine oxidase A LEFLUNOMIDE Monoamine Oxidase MAOA 69% 20.696uM NoneNone View
cholinergic receptor, muscarinic 3 TROPISETRON Muscarinic M3 69% NoneNone NoneNone View
Sigma-2 Receptor QUINACRINE Sigma2 69% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) SERTRALINE Adrenergic alpha1D 69% NoneNone NoneNone View
dopamine receptor D3 ORPHENADRINE Dopamine D3 69% NoneNone NoneNone View
aldo-keto reductase family 1, member B4 (aldose reductase) NIFURSOL Aldose Reductase 69% NoneNone NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) NIFURSOL Aldose Reductase 69% NoneNone NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) NIFURSOL Aldose Reductase 69% NoneNone NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) NIFURSOL Aldose Reductase 69% NoneNone NoneNone View
aldo-keto reductase family 1, member B4 (aldose reductase) CHLORAMBUCIL Aldose Reductase 69% 9.413uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) CHLORAMBUCIL Aldose Reductase 69% 9.413uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) CHLORAMBUCIL Aldose Reductase 69% 9.413uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) CHLORAMBUCIL Aldose Reductase 69% 9.413uM NoneNone View
adenosine A2a receptor SB-203580 Adenosine A2A 69% 6.068uM 3.407uM View
matrix metalloproteinase 1 (interstitial collagenase) NISOLDIPINE Protease, Matrix Metalloprotease-1 (MMP-1) 69% NoneNone NoneNone View
opioid receptor, delta 1 ASTEMIZOLE Opiate delta 69% 12.979uM 4.575uM View
cholinergic receptor, muscarinic 4 DOXAZOSIN Muscarinic M4 69% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 HALOPROGIN Muscarinic M4 69% NoneNone NoneNone View
adrenergic receptor, alpha 2b DIPHENHYDRAMINE Adrenergic alpha2B 69% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 DOXAZOSIN Adrenergic, Norepinephrine Transporter 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) AMOXAPINE Sodium Channel, Site 2 69% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DESLORATADINE Sodium Channel, Site 2 67% NoneNone NoneNone View